Compass Pathways Plc

  • Safety Score
  • Market Cap $320.98M
  • PE -2
  • Debt $32.16M
  • Cash $207.34M
  • EV $145.79M
  • FCF -$105.21M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$144.32M
EBIT-$143.36M
ROE-75%
ROA-58%
FCF-$105.21M
Equity$193.03M
Growth Stability1
PE-2.22
PB1.66
P/FCF-3.05
Price/Cash0.65
Debt/Equity0.17
Debt/FCF-0.31
Equity CAGR-3%
Earnings Growth YoY15%
Earnings Growth QoQ1%
Equity CAGR 5Y-3%
Equity CAGR 3Y-4%
Market Cap$320.98M
Assets$247.34M
Total Debt$32.16M
Cash$207.34M
Shares Outstanding66.94M
EV145.79M
Safety Score65%
Working Capital207.45M
Current Ratio8.91
Shares Growth 3y22%
Equity Growth QoQ-15%
Equity Growth YoY-24%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

SEC Filings

Direct access to Compass Pathways Plc (CMPS) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Compass Pathways Plc compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Compass Pathways Plc compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Compass Pathways Plc Discounted Cash Flow

Fully customizable DCF calculator online for Compass Pathways Plc.

= -$1.1B
012345678910TV
fcf-$105M-$105M-$105M-$105M-$105M-$105M-$105M-$105M-$105M-$105M-$105M-$1.1B
DCF-$96M-$87M-$79M-$72M-$65M-$59M-$54M-$49M-$45M-$41M-$406M
Value-$1.1B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201912/202012/202112/202212/2023TTM
Net Margins------
ROA--25%-24%-46%-43%-58%
ROE--31%-25%-50%-52%-75%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201912/202012/202112/202212/2023TTM
Debt over FCF--0--0-0.31-0.31
Debt over Equity-0.410-00.130.17
Growth Stability-----1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth------
Earnings YoY growth-208%19%28%29%-
Equity YoY growth--747%45%-36%25%-3%
FCF YoY growth-131%64%56%-8%-